New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most

By Rebecca Robbins and Stephanie Nolen from NYT Health https://ift.tt/FVEHuq0
Sickle Cell Anemia, Genetic Engineering, Blood, Genetics and Heredity, Income Inequality, Bone Marrow, Drugs (Pharmaceuticals), Therapy and Rehabilitation, Developing Countries, Crispr (DNA), Transplants, Stem Cells, your-feed-science, your-feed-healthcare